Heart disease is on the rise globally, and it has been for over two decades. Ischemic heart disease is the world’s single biggest killer, responsible for 13% of all deaths worldwide. Since 2000, deaths from this one condition alone climbed by 2.7 million, reaching 9.1 million in 2021. The trend is projected to accelerate: total cardiovascular disease prevalence is expected to increase by 90% between 2025 and 2050, with annual deaths climbing from 20.5 million to 35.6 million over that period.
But the full picture is more nuanced than those numbers suggest. The rise is driven largely by aging populations and a handful of preventable risk factors, and it’s hitting some groups far harder than others.
What the Global Numbers Show
Cardiovascular disease, which includes heart attacks, heart failure, stroke, and related conditions, kills more people than any other cause. An estimated 20.5 million people will die from it in 2025. By 2050, that number is projected to hit 35.6 million, a 73% jump in raw deaths. Ischemic heart disease, the type caused by blocked coronary arteries, will remain the dominant killer, accounting for roughly 20 million of those deaths in 2050.
Here’s the important distinction: the age-adjusted rate of cardiovascular disease is actually projected to drop slightly (about 3.6%) over the same period, and age-adjusted mortality could fall by around 30%. That means if the world’s population stayed the same age, heart disease would be declining. But because people are living longer in nearly every country, more individuals are reaching the ages where heart disease becomes common. The raw numbers keep climbing even as prevention and treatment improve.
Heart Disease in the United States
In the U.S., heart disease remains the leading cause of death. The most recent national data shows 680,981 Americans dying from heart disease annually, a rate of about 203 deaths per 100,000 people. That’s roughly one in every five deaths.
Income plays a significant and growing role. Research published in JAMA Network Open found that disparities in cardiovascular disease prevalence between the highest-income Americans and everyone else are substantial and widening. People with fewer financial resources face higher rates of heart disease, likely driven by differences in diet quality, access to preventive care, chronic stress, and the ability to manage conditions like high blood pressure and diabetes before they cause lasting damage.
Why Younger Adults Are Affected More
One of the more alarming trends is that heart attacks are becoming more common in younger people. Data from the American College of Cardiology covering 2000 to 2016 found that the proportion of heart attacks occurring in very young adults increased by about 2% per year over the final decade of the study. This isn’t a massive shift in absolute numbers, but it represents a clear, steady trend in the wrong direction among people who were traditionally considered too young for heart attacks.
The likely culprits are the same risk factors hitting the broader population earlier in life: obesity, type 2 diabetes, and high blood pressure are all appearing at younger ages than they did a generation ago. About one-quarter of the global population now meets the criteria for metabolic syndrome, a cluster of conditions including excess abdominal fat, high blood sugar, abnormal cholesterol, and elevated blood pressure that dramatically increases cardiovascular risk. That proportion is expected to keep rising alongside obesity and diabetes rates.
The Role of Uncontrolled Blood Pressure
High blood pressure is the single most important modifiable risk factor for heart disease, and globally, it remains poorly managed. An estimated 1.28 billion adults between ages 30 and 79 have hypertension. Of those, only about 23% of women and 18% of men have their blood pressure adequately controlled. That means the vast majority of people with high blood pressure are walking around with a major, treatable risk factor doing ongoing damage to their hearts and blood vessels.
The gap between how many people have hypertension and how many are treated effectively is one of the biggest reasons heart disease continues to climb in low- and middle-income countries, where access to affordable medication and routine monitoring is limited.
COVID-19 Added a New Layer of Risk
The pandemic introduced a cardiovascular threat that researchers are still measuring. A systematic review and meta-analysis published in Frontiers in Cardiovascular Medicine found that people who had COVID-19 faced significantly elevated risks of multiple heart conditions four or more weeks after their initial infection. Compared to people who never had COVID, long COVID patients had roughly 1.6 to 1.7 times the risk of developing coronary heart disease, stroke, irregular heart rhythms, heart failure, and high blood pressure. The risk of heart muscle inflammation (myocarditis) was about six times higher, and blood clot disorders were roughly three times more likely.
In absolute terms, the excess risk for any single individual is small. But spread across hundreds of millions of infections worldwide, even modest increases in cardiovascular risk translate to a measurable bump in total cases. This is an added pressure on heart disease statistics that didn’t exist before 2020.
Prevention Tools Are Effective but Underused
The frustrating reality is that most heart disease is preventable or at least delayable. Cholesterol-lowering medications, when taken consistently, reduce the risk of a first cardiovascular event by 16% to 30% depending on a person’s baseline risk level. Blood pressure medications are similarly effective when people actually take them. The problem isn’t that treatments don’t work. It’s that too few people receive them, stay on them, or have access to them in the first place.
Lifestyle factors remain the foundation. Regular physical activity, not smoking, maintaining a healthy weight, and eating a diet low in processed foods collectively eliminate the majority of cardiovascular risk for most people. Yet global trends in obesity, sedentary behavior, and processed food consumption are all moving in the wrong direction, which is why the disease burden keeps growing even as medical science gets better at treating it.
The bottom line: heart disease is rising in total cases and total deaths worldwide, and it will continue to rise for decades. The age-adjusted rate is improving slightly, meaning medicine and prevention are working for those who benefit from them. But population aging, expanding waistlines, undertreated blood pressure, and now the long-term cardiovascular effects of COVID-19 are collectively outpacing those gains.